Center Care (Meritain) policies, page 93

Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Center Care (Meritain), by title.

Center Care (Meritain) policies
PolicyDetailsCodesSource
Acthar-Purified Cortrophin Gel 3171-A RI eSGM P20243171-A · Commercial—Original policy ↗
Actimmune SGM 2375-A P20252375-A · Commercial—Original policy ↗
Actinic Keratoses Treatments0567 · Commercial49Original policy ↗
AcuTect Scintigraphic Imaging for Detection of Lower Limb Deep Vein Thrombosis0414 · Commercial6Original policy ↗
Adalimumab0655 · Commercial62Original policy ↗
ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP)0780 · Commercial15Original policy ↗
Adbry 5125-A SGM P20245125-A · Commercial—Original policy ↗
ADHD Agents Post Limit PA 1218-J, 683-J P12-2025 v21218-J, 683-J · Commercial—Original policy ↗
ADHD ST, Post PA (ACF FI Only) Policy 2937-D 11-20202937-D · Commercial—Original policy ↗
Adoptive Immunotherapy and Cellular Therapy0641 · Commercial9Original policy ↗
Aerosolized or Irrigated Anti-infectives for Sinusitis0593 · Commercial10Original policy ↗
Akynzeo Limit Policy 1211-H 01-20231211-H · Commercial—Original policy ↗
Albendazole, Biltricide, Egaten, Emverm Post Limit PA 1586-J P03-20261586-J · Commercial—Original policy ↗
Albenza, Biltricide, Egaten, Emverm Limit Policy 1583-H UDR 03-20241583-H · Commercial—Original policy ↗
Aldara Limit Policy 2959-H UDR 08-20232959-H · Commercial—Original policy ↗
Aldara Limit Policy 2959-H UDR 08-20232959-H · Commercial—Original policy ↗
Aldurazyme 2049-A SGM P20232049-A · Commercial—Original policy ↗
Alecensa 2150-A SGM P20222150-A · Commercial—Original policy ↗
Alecensa 2150-A SGM P2024a2150-A SGM P2024a · Commercial—Original policy ↗
Alinia Limit with Age 9-I P03-2026P03-2026 · Commercial—Original policy ↗
Alinia Limit with Age Policy 9-I 03-20239-I · Commercial—Original policy ↗
Allograft Transplants of the Extremities0364 · Commercial26Original policy ↗
Alopecia Areata0423 · Commercial72Original policy ↗
Alunbrig 1815-A SGM P20231815-A · Commercial—Original policy ↗
Alveoloplasty - Surgical Preparation of Ridge in Preparation for a Prosthesis (010)010 · Effective Mar 13, 2026 · Commercial5Original policy ↗
Alzheimer's Disease Tests0349 · Commercial60Original policy ↗
Ambien ST, Post PA (Aetna FI ACF, Aetna FI ACFC Only) Policy 2925-D 04-20222925-D · Commercial—Original policy ↗
Ambulatory Assist Devices: Canes, Crutches, and Walkers0505 · Commercial38Original policy ↗
Ambulatory Electroencephalography0425 · Commercial33Original policy ↗
Amitiza PA 13-A, 990-A P10-202513-A, 990-A P10-2025 · Commercial—Original policy ↗
Amnioinfusion0417 · Commercial5Original policy ↗
Anesthetic and Antiemetic Infusion Pumps0607 · Commercial44Original policy ↗
Ankle Orthoses, Ankle-Foot Orthoses (AFOs), and Knee-Ankle-Foot Orthoses (KAFOs)0565 · Commercial146Original policy ↗
Antepartum Fetal Surveillance0088 · Commercial16Original policy ↗
Anthrax0483 · Commercial30Original policy ↗
Antibody Tests for Neurologic Diseases0340 · Commercial22Original policy ↗
Antidiabetic GLP-1, GIP-GLP-1 Agonist PA with Logic 5694-D P05-20255694-D · Commercial—Original policy ↗
Antiemetic 5-HT3 Post Limit PA 16-J P01-202516-J P01-2025 · Commercial—Original policy ↗
Antiemetic 5-HT3 Post Limit PA Policy 16-J 02-202216-J · Commercial—Original policy ↗
Antiemetic 5-HT3 Post Limit PA REG 2821-J 01-2024 v2_R2821-J · Commercial—Original policy ↗
Antiemetic NK1 Limit 78-H P01-2026 v2P01-2026 v2 · Commercial—Original policy ↗
Antiemetic Therapy0724 · Commercial152Original policy ↗
Antifungal Topical Combinations Limit, Post PA 2912-HJ P04-20262912-HJ · Commercial—Original policy ↗
Antifungal Topical ST, Post PA Policy 1380-D UDR 08-20231380-D · Commercial—Original policy ↗
Antineoplaston Therapy0240 · Commercial—Original policy ↗
Apnea Monitors for Infants0003 · Commercial10Original policy ↗
Apokyn-Kynmobi 2258-A SGM P20222258-A · Commercial—Original policy ↗
apomorphine-Apokyn-Kynmobi SGM 2258-A P2024_R2258-A P2024_R · Commercial—Original policy ↗
Aranesp 1616-A SGM P20201616-A · Commercial—Original policy ↗
Arazlo PA 3496-A P08-2024_R3496-A · Commercial—Original policy ↗

Back to Center Care (Meritain)

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.